Does SETMELANOTIDE Cause Product dose omission issue? 15 Reports in FDA Database
Lose Weight Fast — The 21-Day Smoothie Diet
36 fat-burning recipes + shopping lists. Results in the first week.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Product dose omission issue have been filed in association with SETMELANOTIDE (Imcivree). This represents 8.2% of all adverse event reports for SETMELANOTIDE.
15
Reports of Product dose omission issue with SETMELANOTIDE
8.2%
of all SETMELANOTIDE reports
0
Deaths
5
Hospitalizations
How Dangerous Is Product dose omission issue From SETMELANOTIDE?
Of the 15 reports, 5 (33.3%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SETMELANOTIDE. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does SETMELANOTIDE Cause?
Nausea (53)
Off label use (48)
Skin hyperpigmentation (43)
Headache (27)
Skin discolouration (26)
Diarrhoea (24)
Vomiting (24)
Fatigue (23)
Decreased appetite (19)
Injection site pruritus (19)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which SETMELANOTIDE Alternatives Have Lower Product dose omission issue Risk?
SETMELANOTIDE vs SEVELAMER
SETMELANOTIDE vs SEVOFLURANE
SETMELANOTIDE vs SIBUTRAMINE
SETMELANOTIDE vs SILDENAFIL
SETMELANOTIDE vs SILODOSIN